Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) shot up 29.7% during mid-day trading on Thursday . The stock traded as high as GBX 1,888 ($25.62) and last traded at GBX 1,801.01 ($24.44). 4,439,258 shares changed hands during mid-day trading, an increase of 61% from the average session volume of 2,754,210 shares. The stock had previously closed at GBX 1,389 ($18.85).
Johnson Matthey Price Performance
The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The company has a 50-day moving average of GBX 1,313.40 and a 200-day moving average of GBX 1,377.22. The stock has a market cap of £2.85 billion, a price-to-earnings ratio of 28.96, a PEG ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. As a group, equities research analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This is a positive change from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. The ex-dividend date was Thursday, April 10th. Johnson Matthey's dividend payout ratio (DPR) is 130.84%.
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon purchased 30 shares of the business's stock in a transaction dated Wednesday, April 16th. The shares were bought at an average price of GBX 1,200 ($16.28) per share, with a total value of £360 ($488.47). Insiders have purchased 75 shares of company stock valued at $99,927 over the last three months. 0.61% of the stock is owned by company insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Read More
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
